Pelthos Therapeutics PTHS
NYSE PTHS
$17.02 -2.57 (-13.11%)
As of: Oct 23, 2026 · 3:59 PM EDT

Pelthos Therapeutics (PTHS) Amortization of Deferred Charges (2023 - 2026)

Updated

Analysis

Pelthos Therapeutics (PTHS) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Pelthos Therapeutics 60.49 Mn -27.90 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 237,000.00
Mar 31, 2026 195,000.00
Jun 30, 2025 165,000.00
Mar 31, 2025 94,000.00
Dec 31, 2024 76,000.00
Sep 30, 2024 10,370.00
Mar 31, 2024 605,630.00
Dec 31, 2023 121,333.00
Sep 30, 2023 17,664.00
Jun 30, 2023 17,472.00
Mar 31, 2023 31,650.00
API Access

Pelthos Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PTHS&period=max&api_key=YOUR_API_KEY